RBC Capital Reinstates Outperform on Bio-Rad Laboratories, Announces $320 Price Target
Bio Rad Laboratories Inc BIO
$247.53
▲ +0.51%
(+$1.26)
Open
$248.46
Prev Close
$246.27
Day Range
$242.79 – $250.10
52W Range
$211.43 – $343.12
Market Cap
$6.73B
P/E (TTM)
39.87
Beta
1.03
EPS (TTM)
$6.07
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1980-03-17 |
| Shares Out. | 26,990,000 |
| Website | bio-rad.com/ ↗ |
| Phone | 13026587581 |
Bio Rad Laboratories Inc is a publicly traded company under the ticker symbol BIO on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-05-01)
📰 Latest News for BIO
Bio-Rad to Participate in Upcoming Investor Conferences
Ariel Focus Fund Q1 2026 Performers And Detractors
Ariel Investments Re-added Bio-Rad Laboratories (BIO) as Strong Margins and Market Leadership Stand Out
[Latest] Global Targeted DNA RNA Sequencing Market Size/Share Worth USD 46.9 Billion by 2035 at a 18.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
How The Biocon (NSEI:BIOCON) Story Is Shifting As Analysts Recut Growth And Risk Assumptions
Bio-Rad (BIO) Q2 2025 Earnings Call Transcript
Unlocking Bio-Rad (BIO) International Revenues: Trends, Surprises, and Prospects